dihexa peptide sciences DIHEXA CAPSULES | High-Purity Peptide

Benefits (Research Focus) NNMT inhibition studied as a selective small-molecule inhibitor of nicotinamide N-methyltransferase NAD+ preservation investigated for preservation of cellular NAD+ pools and downstream sirtuin pathway activity Adipose tissue research explored for lipolysis markers and fat-mass partitioning in DIO rodent models Skeletal muscle metabolism examined for endpoints related to muscle aging and sarcopenia models Metabolic signaling researched for glucose homeostasis and insulin sensitivity endpoints in metabolic disease models What Researchers Look At NNMT enzymatic activity and 1-methylnicotinamide (1-MNA) tissue concentrations Intracellular NAD+ / NADH ratio and downstream sirtuin (SIRT1/SIRT3) activation Body composition, fat mass, and lean mass partitioning in DIO rodent models Adipocyte lipolysis markers and adipose tissue inflammation profiles Glucose tolerance, insulin sensitivity, and hepatic steatosis endpoints Quick Specs Form: Lyophilized white powder Net Content: 50 mg per vial (as iodide salt) Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: 5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) Synonyms: 5-Amino-1-methylquinolinium

Lorenzen JM, Thum T

Informed Consent Statement Informed consent was obtained from all subjects involved in the study

ROS prioritizes patient education, transparency, and the ethical application of peptide therapy, offering treatments backed by scientific research and clinical experience

BPC-157 + TB-500 Blend Dual Peptide Research Compound Compound Name: BPC-157 + TB-500 Blend Classification: Research Peptides Pentadecapeptide + Thymosin Beta-4 Fragment Description: The BPC-157 + TB-500 blend combines two synthetic research peptides that are frequently examined together in controlled laboratory environments due to their complementary roles in peptide-mediated signaling and cellular pathway modeling

Some research-planning protocols cap weekly SubQ at ~300 mg without further evaluation